NO912942L - Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. - Google Patents

Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.

Info

Publication number
NO912942L
NO912942L NO91912942A NO912942A NO912942L NO 912942 L NO912942 L NO 912942L NO 91912942 A NO91912942 A NO 91912942A NO 912942 A NO912942 A NO 912942A NO 912942 L NO912942 L NO 912942L
Authority
NO
Norway
Prior art keywords
vaccine
infection
liverability
drugs
preventive treatment
Prior art date
Application number
NO91912942A
Other languages
English (en)
Other versions
NO912942D0 (no
Inventor
Sonia Louise Crameri
Michael Panaccio
Lachlan Robert Wilson
Gene Louise Wijffels
Terence William Spithill
Noel John Campbell
Catriona Mary Thompson
Jennifer Louise Sexton
Andrew Richard Milner
Graham Frank Mitshell
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of NO912942D0 publication Critical patent/NO912942D0/no
Publication of NO912942L publication Critical patent/NO912942L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vaksine for forebyggende behandling mot infeksjon av leverikte hos drøvtyggere, hvor antigenet er glutation- S-transferase ekstrahert fra voksne ormer fra F. hepatica. Antigenet kan også være syntetisk ekvivalente molekyler og ekvivalente molekyler fremstilt ved rekombinante DNA-teknikker. Metoder for fremstilling er også beskrevet.
NO91912942A 1989-01-31 1991-07-29 Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere. NO912942L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ248189 1989-01-31
PCT/AU1990/000027 WO1990008819A1 (en) 1989-01-31 1990-01-31 Vaccine for the preventative treatment of infection of liver fluke in ruminants

Publications (2)

Publication Number Publication Date
NO912942D0 NO912942D0 (no) 1991-07-29
NO912942L true NO912942L (no) 1991-09-26

Family

ID=3773671

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912942A NO912942L (no) 1989-01-31 1991-07-29 Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.

Country Status (8)

Country Link
EP (1) EP0456662A4 (no)
JP (1) JPH04507235A (no)
AU (1) AU634754B2 (no)
BR (1) BR9007070A (no)
CA (1) CA2045663A1 (no)
NO (1) NO912942L (no)
NZ (1) NZ232327A (no)
WO (1) WO1990008819A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657883A1 (no) * 1990-02-07 1991-08-09 Transgene Sa
GB9018238D0 (en) * 1990-08-20 1990-10-03 Trudgett Alan G Liver fluke diagnostic system
ES2199947T3 (es) * 1992-10-21 2004-03-01 John Pius Dalton Vacuna que contiene una tiolproteasa.
NZ261279A (en) * 1993-02-05 1996-03-26 Daratech Pty Ltd Polypeptide able to induce an immune response against a helminth and vaccines containing it
JPH09502988A (ja) * 1993-09-28 1997-03-25 ザ・ユニバーシテイ・オブ・メルボルン 寄生虫に対する感染防御抗原
CN1061990C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(一)
CN1061991C (zh) * 1994-06-08 2001-02-14 北京医科大学 新型血吸虫疫苗肽(三)
CN1068334C (zh) * 1994-06-08 2001-07-11 北京医科大学 新型血吸虫疫苗肽(二)
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
CN105903007A (zh) * 2016-06-15 2016-08-31 青海大学 一种新型肝片吸虫多表位疫苗的设计、制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors

Also Published As

Publication number Publication date
BR9007070A (pt) 1991-11-12
AU5028390A (en) 1990-08-24
NZ232327A (en) 1993-02-25
JPH04507235A (ja) 1992-12-17
WO1990008819A1 (en) 1990-08-09
CA2045663A1 (en) 1990-08-01
EP0456662A1 (en) 1991-11-21
AU634754B2 (en) 1993-03-04
NO912942D0 (no) 1991-07-29
EP0456662A4 (en) 1991-12-11

Similar Documents

Publication Publication Date Title
Youn et al. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis.
AU4533589A (en) Skin test and test kit for aids
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
EA200201280A1 (ru) Стрептококковые антигены
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
DE68907679D1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweg-geschwuerkrankheiten.
FI882707A7 (fi) Menetelmä ja valmiste maidon proteiinipitoisuuden lisäämiseksi.
IE871203L (en) Formulations containing unsaturated fatty acids
EP0313378A3 (en) Methods and compositions for transient elimination of humoral immune antibodies
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
ATE243750T1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
ATE130198T1 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
ATE222930T1 (de) Antigene arznei zur behandlung oder vorbeugung
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE3751772D1 (de) Impfstoff zur behandlung von hsv
ATE237691T1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
EP0251460A3 (en) Method for producing hepatitis b virus core antigen (hbcag) in yeast
Tu et al. Comparison of Naja naja siamensis and Naja naja atra venoms
ES8303916A1 (es) "un metodo para preparar el antigeno de superficie de la hepatitis b puro a partir de plasma humano".
Sun et al. Effect of selenium in recovery of immunity damaged by H2O2 and60Co radiation
DE69030181D1 (de) Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege